Research Options:

Week of Expected Pricing 4/23/2021
Company Name ZYMERGEN INC
Proposed Ticker ZY
CUSIP 98985X100
Business Description The Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets and naturally derived UV protection. We create new products with a proprietary platform that unlocks the design and manufacturing efficiency of biological processes with technology’s ability to rapidly iterate and control diverse functions. We call our process biofacturing and it creates better products faster, cheaper and more sustainably than traditional chemistry by engineering microbes to make novel biomolecules that are the key ingredients in those products. Our goal is to launch our products in about half the time and 1/10th of the cost of what traditional chemicals and materials companies can deliver, which would allow us to address a wide array of commercial applications.
Lead Underwriter Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC
Co-Managers BofA Securities, Inc, Cowen and Company, LLC, Lazard Frères & Co. LLC, UBS Investment Bank
Initial Shares 1,36,00,000
Revised Initial Shares 1,61,30,000
Initial Price $28.00-$31.00
Revised Price N/A
Final Price $31.00
Final Ticker ZY

 

 

   
  © 2024 ICE Data Services. All rights reserved.